Healthcare and Life Science
Bio-Rad extends range of Foresight Pro prepacked chromatography columns for biotherapeutic production
Foresight Pro 45 cm ID Column Provides a Convenient and Reliable Solution for Purification of Biomolecules in Downstream BioprocessingHERCULES, Calif. — January 7, 2025 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics ...
Addressing nitrosamine analysis challenges in pharmaceuticals with the ATNA
Detecting nitrosamines in pharmaceutical products is essential for maintaining safety and ensuring regulatory compliance. Following high-profile recalls involving nitrosamine impurities, such as N-Nitrosodimethylamine (NDMA), regulatory bodies like the FDA and EMA now require pharmaceut...
Breeio’s AI-powered learning portal helps Priory win nursing award
A 20-year relationship that began with a ground-breaking e-learning initiative that won industry awards for 'Best e-Learning Project' and a 'National Training Award' has continued, as Acteon and Priory win another prestigious award for their innovation in learning and development.Priory...
No more “Tech Grinch” excuses in 2025!
Santa may only come once a year, but your IT Support and Cyber Security strategy needs to work for you 24/7! 2025 is set to be a year of growth and opportunity - but only if your team has the tools to succeed.Our MD’s has created a free guide covering the 5 must-haves for an effect...
Bio-Rad receives NF validation for iQ-Check Listeria spp. and iQ-Check Listeria monocytogenes shortened enrichment protocol in all food products and environmental samples
HERCULES, Calif. — December 16, — 2024 Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostic products, announces that NF Validation (AFNOR) has approved the extension of certification of the iQ-Check™ Listeria spp. a...
Capacity is the new capability: meeting market demand
At the recent PDA Universe of Prefilled Syringes and Injection Devices conference in Phoenix Arizona, there were many conversations about the manufacturing landscape for drug delivery devices. ...
More needs to be done to help the NHS with their sustainability targets
This year’s theme at ReMed was ‘Beyond Disposable: Building a Circular Economy for Medical Devices’ and had a focus on interdisciplinary collaboration. The common theme throughout the conference was the recognition and drive to take practical, immediate actions towards a more circu...
The rise of the next-Ggn CDMO: strategies for reducing risk and time to market
Creating and producing advanced drug-device combinations, like autoinjectors and pen injectors, requires a depth and breadth of technical expertise. As more pharmaceutical companies streamline their supply chains and outsource specialised technical tasks, these challenges are increasing...
Scalable solutions for sample preparation in diagnostics: a practical perspective
Advances in precision medicine and diagnostics over the past decade have the potential to improve patient outcomes by decreasing the time needed to identify a disease or pathogen and adjust patient treatment, whether they are to address rising cases of antibiotic resistance, viral epide...
Does my medical device design actually work?
There are few experiences that can surpass the joy of seeing a product you developed reach manufacture. But before that, you face the non-trivial task of proving your current embodiment can actually work and meet its design intent. This stage, often referred to as the “proof of feasibil...